Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways
- PMID: 28190476
- DOI: 10.1016/j.phymed.2016.12.017
Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways
Abstract
Background: Epimedium sagittatum is a traditional Chinese herb normally which is used to treat the osteoporosis, cardiovascular dysfunction, and to improve neurological and sexual function in China, Korea and Japan. Icariin is the major active ingredient in Epimedium sagittatum. In the present research, we examined the neuroprotective effects of icariin on dopaminergic neurons and the possible mechanisms in a mouse model of Parkinson's disease (PD).
Methods: Ovariectomized PD mice were treated with vehicle or icariin (3 days before MPTP injections) with or without the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 or mitogen-activated protein kinase kinase (MEK) inhibitor PD98059. The dopamine (DA) content in the striatum was studied by HPLC. Western blot was used to determine the protein expressions of Bcl-2, Bax and Caspase 3 in the striatum. The numbers of tyrosine hydroxylase-immunoreactive (TH-IR) neurons in the substantial nigra pars compacta (SNpc) were assessed by immunohistochemistry. The activation of Akt and ERK by icariin were detected in doparminergic MES23.5 cells.
Results: Icariin pretreatment could ameliorate the decreased striatum DA content and the loss of TH-IR neurons in the SNpc induced by MPTP. The MPTP-induced changes of Bcl-2, Bax and caspase 3 protein expressions in the striatum could be reversed by icariin pretreatment. Blockade of PI3K/Akt or MEK/ERK signaling pathway by LY294002 or PD98059 could attenuate the increase of DA content in the striatum and TH-IR in the SNpc induced by icariin in PD mice model. Additionally, icariin treatment alone significantly induced the phosphorylation of Akt and ERK in a time dependent pattern in dopaminergic MES 23.5 cells. These effects were abolished by co-treatment with LY294002 or PD98059.
Conclusion: These data demonstrated that icariin has neuroprotective effect on dopaminergic neurons in PD mice model and the potential mechanisms might be related to PI3K/Akt and MEK/ERK pathways.
Keywords: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Dopamine; Icariin; Mitogen-activated protein kinase kinase; Parkinson's disease; Phosphatidylinositol 3-kinase.
Copyright © 2016 Elsevier GmbH. All rights reserved.
Similar articles
-
Neuroprotective effects of total flavonoid fraction of the Epimedium koreanum Nakai extract on dopaminergic neurons: In vivo and in vitro.Biomed Pharmacother. 2017 Jul;91:656-663. doi: 10.1016/j.biopha.2017.04.083. Epub 2017 May 8. Biomed Pharmacother. 2017. PMID: 28494419
-
Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.Int J Mol Sci. 2022 Feb 21;23(4):2388. doi: 10.3390/ijms23042388. Int J Mol Sci. 2022. PMID: 35216503 Free PMC article.
-
Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo.J Ethnopharmacol. 2010 Sep 15;131(2):433-42. doi: 10.1016/j.jep.2010.07.008. Epub 2010 Jul 13. J Ethnopharmacol. 2010. PMID: 20633628
-
Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review.Life Sci. 2020 Sep 15;257:118019. doi: 10.1016/j.lfs.2020.118019. Epub 2020 Jul 3. Life Sci. 2020. PMID: 32629002 Review.
-
The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.Curr Pharm Des. 2011;17(5):489-507. doi: 10.2174/138161211795164095. Curr Pharm Des. 2011. PMID: 21375482 Review.
Cited by
-
Icariin prevents methylmercury-induced experimental neurotoxicity: Evidence from cerebrospinal fluid, blood plasma, brain samples, and in-silico investigations.Heliyon. 2024 Jan 6;10(1):e24050. doi: 10.1016/j.heliyon.2024.e24050. eCollection 2024 Jan 15. Heliyon. 2024. PMID: 38226245 Free PMC article.
-
Polyphenols Targeting MAP Kinase Signaling Pathway in Neurological Diseases: Understanding Molecular Mechanisms and Therapeutic Targets.Mol Neurobiol. 2023 Nov 3. doi: 10.1007/s12035-023-03706-z. Online ahead of print. Mol Neurobiol. 2023. PMID: 37922063 Review.
-
Effects of Tiliroside and Lisuride Co-Treatment on the PI3K/Akt Signal Pathway: Modulating Neuroinflammation and Apoptosis in Parkinson's Disease.Biomedicines. 2023 Oct 9;11(10):2735. doi: 10.3390/biomedicines11102735. Biomedicines. 2023. PMID: 37893109 Free PMC article.
-
Menstrual blood-derived endometrial stem cells alleviate neuroinflammation by modulating M1/M2 polarization in cell and rat Parkinson's disease models.Stem Cell Res Ther. 2023 Apr 13;14(1):85. doi: 10.1186/s13287-023-03330-7. Stem Cell Res Ther. 2023. PMID: 37055866 Free PMC article.
-
A clinical herbal prescription Gu-Shu-Kang capsule exerted beneficial effects on the musculoskeletal system of dexamethasone-treated mice by acting on tissue IGF-1 signalling pathway.Pharm Biol. 2022 Dec;60(1):2098-2109. doi: 10.1080/13880209.2022.2132029. Pharm Biol. 2022. PMID: 36269032 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
